Labcorp , a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp's acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. This acquisition i…
Cytiva, a Danaher company and a global leader in the life sciences industry, and WhiteLab Genomics, a techbio company specializing in artificial intelligence for genomic medicine research and development, announced a collaboration to accelerate the development of next-generation genomic medicines. As part of this col…
SOPHiA GENETICS a cloud-native healthcare technology company and a global leader in data-driven medicine, has announced a significant new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium.…
Zydus Lifesciences Ltd. a global innovation-driven healthcare company, announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Synthon BV of the Netherlands for Ozanimod Capsules (a generic version of ZEPOSIA®) for the U.S. market. S…
LOTTE BIOLOGICS announced that it has entered a late-stage to commercial contract manufacturing partnership with a U.S.-based global biopharmaceutical company. The partnership covers a late-stage Phase 3 program that is advancing into multiple new indications, and extends to commercial supply following potential regu…
IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence, and Flagship Pioneering, the bioplatform innovation company, announced a strategic collaboration to accelerate the development of breakthrough life sciences companies. The collaboration will help the Flagsh…
OPTEL Group, a global leader in pharmaceutical traceability and supply chain solutions, proudly announces the acquisition of Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. This strategic move reinforces OPTEL's commitment to innovation and positions the company at the forefront of …
Northwest Biotherapeutics, Inc. a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced that it has entered into an agreement to acquire Advent BioServices Ltd. from its owner, Toucan Holdings LLC. The transaction is expected to close as soon as certain legal condition…
Boehringer Ingelheim and LEO Pharma announced an exclusive global license and transfer agreement to commercialize and advance the development of SPEVIGO. Under the terms of the agreement, LEO Pharma will be responsible for commercialization and further development of SPEVIGO® leveraging its global commercial platform…
Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutical company, for the development, manufacturing and commercialization of SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, currently undergoing several clinic…
Page 32 of 40